Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
NCT07064226

Validation of a Digital Intervention to Rehabilitate Cognitive Resources

Led by Fondazione Don Carlo Gnocchi Onlus · Updated on 2026-02-13

102

Participants Needed

1

Research Sites

103 weeks

Total Duration

On this page

Sponsors

F

Fondazione Don Carlo Gnocchi Onlus

Lead Sponsor

U

Università Carlo Cattaneo , Castellanza

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if the use of a digital cognitive rehabilitation system named RICORDO, that is flexible and capable of adapting the rehabilitation pathway according to the needs and capacity of the patients will prove effective for subjects with Subjective Memory Complaint or with Mild Cognitive Impairment or with Mild Dementia. The main questions it aims to answer are: Will the RICORDO rehabilitation treatment, lead to an improvement in the global cognitive level? Will the RICORDO rehabilitation treatment lead to improved activation of participants in managing their own health and healthcare? Researchers will compare the multidomain cognitive rehabilitation strategy of RICORDO digital solution, with a standard paper pencil rehabilitation care (usual care). Participants will undergo a comprehensive neuropsychological evaluation immediately before, immediately after and six months after the completion of the rehabilitation program. Both interventions, the experimental and the usual care, will last 5 weeks, with 3 weekly sessions of 45 minutes each and can be done autonomously by the patient at home.

CONDITIONS

Official Title

Validation of a Digital Intervention to Rehabilitate Cognitive Resources

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Montreal Cognitive Assessment (MoCA) score greater than 17.79
  • Clinical Dementia Rating (CDR) Scale score less than or equal to 1
  • Education level of more than 3 years
  • Age 65 years or older
  • Signed informed consent to participate
  • Availability of a caregiver or study partner to support the participant
  • Stable use of acetylcholinesterase inhibitors for the past 3 months, if applicable
Not Eligible

You will not qualify if you...

  • Presence of dysmetria or severe hearing, vision, or communication problems preventing participation
  • Current rehabilitation program ongoing or within 3 months prior to enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCS Fondazione Don Carlo Gnocchi ONLUS; Center of Advance Diagnostic and Therapy ( CADiTeR)

Milan, Italy, 20148

Actively Recruiting

Loading map...

Research Team

V

Valeria Blasi, MD

CONTACT

C

Chiara Pagliari, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here